Rossmax International Ltd. Stock

Equities

4121

TW0004121009

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
22.75 TWD +1.79% Intraday chart for Rossmax International Ltd. -4.01% -9.00%
Sales 2022 4.34B 133M Sales 2023 3.81B 117M Capitalization 2.12B 65.16M
Net income 2022 170M 5.22M Net income 2023 -6M -184K EV / Sales 2022 0.55 x
Net Debt 2022 302M 9.25M Net Debt 2023 695M 21.32M EV / Sales 2023 0.74 x
P/E ratio 2022
12.2 x
P/E ratio 2023
-313 x
Employees -
Yield 2022
4.91%
Yield 2023
-
Free-Float 66.84%
More Fundamentals * Assessed data
Dynamic Chart
Rossmax International Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Rossmax International Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Rossmax International Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Rossmax International Ltd. Announces Cash Dividend, Payable on July 12, 2023 CI
Rossmax International Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Rossmax International Ltd. Appoints Yan-Ping Chi as Members of the Fifth Term of Compensation Committee CI
Rossmax International Ltd. Proposes Dividend for the Year Ended December 31, 2022 CI
Rossmax International Ltd. Announces Resignation of Fang Ho as A Member of the Audit Committee and the Remuneration Committee CI
Rossmax International Ltd. Announces Resignation of Fang Ho as Independent Director CI
Rossmax International Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
We Can Medicines Co., Ltd. Announces to Change the General Manager CI
Rossmax International Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Rossmax International Ltd. Announces Dividend Distribution, Payable on August 12, 2022 CI
Rossmax International Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Rossmax International Ltd. Proposes Dividend CI
More news
1 day+1.79%
1 week-4.01%
Current month-10.61%
1 month-18.46%
3 months-5.01%
6 months+0.44%
Current year-9.00%
More quotes
1 week
22.00
Extreme 22
23.70
1 month
22.00
Extreme 22
26.95
Current year
22.00
Extreme 22
28.35
1 year
22.00
Extreme 22
36.85
3 years
18.30
Extreme 18.3
36.85
5 years
10.30
Extreme 10.3
36.85
10 years
7.20
Extreme 7.2
36.85
More quotes
Managers TitleAgeSince
Chief Executive Officer - 88-12-12
Director of Finance/CFO - 10-10-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 88-12-12
Director/Board Member - 02-07-28
Director/Board Member - 00-12-26
More insiders
Date Price Change Volume
24-04-24 22.75 +1.79% 365,290
24-04-23 22.35 -0.22% 397,676
24-04-22 22.4 -1.75% 456,243
24-04-19 22.8 -3.80% 473,342
24-04-18 23.7 0.00% 154,362

End-of-day quote Taipei Exchange, April 23, 2024

More quotes
ROSSMAX INTERNATIONAL LTD. is a Taiwan-based company principally engaged in the research, development, manufacture and retailing of medical devices. The Company's main products include digital sphygmomanometers, respiratory therapy products, temperature series products and blood oxygen meters. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas and others.
More about the company